| 000 | 01305 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517073513.0 | ||
| 264 | 0 | _c20160531 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000002487 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yi-Chun | |
| 245 | 0 | 0 |
_aRisks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study. _h[electronic resource] |
| 260 |
_bMedicine _cJan 2016 |
||
| 300 |
_ae2487 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aHsieh, Tsung-Cheng | |
| 700 | 1 | _aChou, Chu-Lin | |
| 700 | 1 | _aWu, Jung-Lun | |
| 700 | 1 | _aFang, Te-Chao | |
| 773 | 0 |
_tMedicine _gvol. 95 _gno. 2 _gp. e2487 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000002487 _zAvailable from publisher's website |
| 999 |
_c25629388 _d25629388 |
||